Post-op Prednisone and Glucose Monitoring in TKA
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorColumbia University
About this trial
This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
Eligibility criteria
Qualifiers
Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty
Age 18 and above
Disqualifiers
Steroid therapy
Narcotic use within past 3 months
History of corticosteroid intolerance
Pregnancy
Trial design
Treatments tested in this trial
- Prednisone
- Continuous Glucose Monitor
- InkWell Health Tattoos
Treatment groups
104 Participants
are divided into 2 treatment groupsSponsors and collaborators
Columbia University
Lead sponsor
Orthopaedic Scientific Research Foundation
Collaborator
Source ClinicalTrials.gov